Skip to content

Integrating Care After Exacerbation of COPD

Integrating Care After Exacerbation of COPD (InCasE)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02021955
Acronym
InCasE
Enrollment
717
Registered
2013-12-27
Start date
2015-02-11
Completion date
2019-01-31
Last updated
2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

randomized controlled trial, quality of life, patient readmission, mortality, patient satisfaction, intervention studies, multicenter study

Brief summary

This clinical trial is designed to determine whether an intervention that provides information to primary care providers about gaps in care for their patients recently discharged from hospital for COPD can reduce hospital re-admissions and mortality and improve their patients' quality-of-life.

Detailed description

Chronic obstructive pulmonary disease (COPD) exacerbations are common among Veterans admitted to hospital, lead to worsening health-related quality of life, and are important drivers of health care expenditures. As many as half of patients discharged for COPD are readmitted within 6 months. An intervention to improve COPD care is needed, not only to treat patients for COPD and their accompanying comorbidities, but also to redesign the care delivery system. The goal of this clinical trial is to test an intervention to improve patient care during the transition from hospital to outpatient setting for patients discharged for COPD. The investigators are targeting the intervention to Patient Aligned Care Team (PACT) providers who are randomized to receive the intervention or not receive the intervention. For the intervention, study clinicians, consisting of experienced primary care providers and pulmonary specialists, reviewed the medical record for each patient discharged from hospital for COPD. The team looked for gaps in care for COPD and key co-morbidities such as obesity, hypertension, diabetes, and cardiovascular disease. They focused on immediate care processes associated with the hospital admission and comorbid disease treatment. For providers in the intervention group, the team placed any patient care recommendations into the medical record using a non-visit consult note and pre-filled order sets. The patient's provider then accepted, modified, or declined any or all of the recommendations based on personal knowledge of the patient's history. The investigators hypothesize that the intervention will: 1) improve patient quality of life; and 2) decrease hospital readmission and mortality after hospital admission for COPD exacerbation.

Interventions

Primary care clinicians receive guideline concordant treatment recommendations for their patients discharged from hospital for a COPD exacerbation.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Providers: * Primary care provider (MD, NP, PA) from VA Puget Sound or Boise VA. * Willingness to participate in the informed consent process and complete interviews and questionnaires. Patients: * Having a provider that is participating in this clinical trial. * Discharged alive with either a primary discharge diagnosis of COPD or acute respiratory failure with a secondary diagnosis of COPD. * Willing and able to participate in the informed consent process and complete interviews and questionnaires.

Exclusion criteria

Providers: none Patients: * Having previously participated in the study. * Significant cognitive dysfunction, language barrier, or severe psychiatric disorder that would preclude completing the questionnaires.

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients With Hospital Re-admission and Mortality180 days post-dischargeComposite measure of hospital readmission for any cause at 180 days and all-cause mortality.
COPD-related Patient Quality-of-life (Clinical COPD Questionnaire)6 weeks post-dischargeself-report survey of patients' quality-of-life with scores ranging from 0-6 with lower scores representing better health; not all participants completed surveys.

Secondary

MeasureTime frameDescription
Patients Participants' General Health Status (Veterans RAND 12 Item Health Survey ) Physical Component Score (VR-12 PCS)6 weeks post-dischargeself-report survey of patients' general physical health quality-of-life scored from 0-100 with higher scores indicating better health.

Countries

United States

Participant flow

Recruitment details

We grouped primary care teams into 30 clusters and randomly assigned each cluster to one of 30 30-day time periods at which time the team would moved from control to intervention. Teams gained and lost providers each month as indicated by addition and attrition below. We also have indicated the number of eligible patient discharges that occurred for each group.

Pre-assignment details

Prior to randomization, 224 providers were invited with 7 refusing, leaving 217 providers included in randomization; 7 additional providers left primary care prior to Step 0, leaving 210 providers who initially participated in the control group in Step 0.

Participants by arm

ArmCount
Provider Participants
all primary care providers: demographic information not collected
365
Control Patient Participants
data for all patients discharged under care of a provider in the control group
191
Intervention Patient Participants
data for all patients discharged under care of a provider in the intervention group
161
Total717

Baseline characteristics

CharacteristicControl Patient ParticipantsIntervention Patient ParticipantsTotalProvider Participants
Age, Continuous69.7 years
STANDARD_DEVIATION 8.6
69.7 years
STANDARD_DEVIATION 8.1
69.7 years
STANDARD_DEVIATION 8.35
Provider type
Attending Physician
66 provider participants66 provider participants
Provider type
Nurse Practitioner/Physician Assistant
38 provider participants38 provider participants
Provider type
Physician Fellow/Resident Physician
35 provider participants35 provider participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants3 Participants4 Participants
Race (NIH/OMB)
Asian
2 Participants3 Participants5 Participants
Race (NIH/OMB)
Black or African American
8 Participants14 Participants22 Participants
Race (NIH/OMB)
More than one race
NA ParticipantsNA ParticipantsNA Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants5 Participants5 Participants
Race (NIH/OMB)
Unknown or Not Reported
14 Participants16 Participants30 Participants
Race (NIH/OMB)
White
166 Participants120 Participants286 Participants
Sex: Female, Male
Female
182 Participants155 Participants337 Participants
Sex: Female, Male
Male
9 Participants6 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
21 / 19115 / 161
other
Total, other adverse events
20 / 19138 / 161
serious
Total, serious adverse events
84 / 19168 / 161

Outcome results

Primary

COPD-related Patient Quality-of-life (Clinical COPD Questionnaire)

self-report survey of patients' quality-of-life with scores ranging from 0-6 with lower scores representing better health; not all participants completed surveys.

Time frame: 6 weeks post-discharge

Population: For 365 enrolled providers, we surveyed 352 patients discharged from hospital for COPD. Not all participants completed surveys.

ArmMeasureValue (MEAN)Dispersion
Usual CareCOPD-related Patient Quality-of-life (Clinical COPD Questionnaire)3.50 CCQ total scoreStandard Deviation 1.22
Guideline Treatment RecommendationsCOPD-related Patient Quality-of-life (Clinical COPD Questionnaire)2.97 CCQ total scoreStandard Deviation 1.2
Primary

Number of Patients With Hospital Re-admission and Mortality

Composite measure of hospital readmission for any cause at 180 days and all-cause mortality.

Time frame: 180 days post-discharge

Population: For 365 enrolled providers, we analyzed 352 patients discharged from hospital for COPD for readmission or mortality

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Usual CareNumber of Patients With Hospital Re-admission and Mortality84 Participants
Guideline Treatment RecommendationsNumber of Patients With Hospital Re-admission and Mortality61 Participants
Secondary

Patients Participants' General Health Status (Veterans RAND 12 Item Health Survey ) Physical Component Score (VR-12 PCS)

self-report survey of patients' general physical health quality-of-life scored from 0-100 with higher scores indicating better health.

Time frame: 6 weeks post-discharge

Population: For 365 enrolled providers, we surveyed 352 patients discharged from hospital for COPD. Not all participants completed surveys.

ArmMeasureValue (MEAN)Dispersion
Usual CarePatients Participants' General Health Status (Veterans RAND 12 Item Health Survey ) Physical Component Score (VR-12 PCS)29.92 units on a scaleStandard Deviation 12.22
Guideline Treatment RecommendationsPatients Participants' General Health Status (Veterans RAND 12 Item Health Survey ) Physical Component Score (VR-12 PCS)33.25 units on a scaleStandard Deviation 11.94

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026